Compare SANDU PHARMA with DIL LIMITED - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs FERMENTA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA FERMENTA BIOTECH SANDU PHARMA/
FERMENTA BIOTECH
 
P/E (TTM) x 22.5 22.8 98.8% View Chart
P/BV x 1.2 2.6 45.6% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 SANDU PHARMA   FERMENTA BIOTECH
EQUITY SHARE DATA
    SANDU PHARMA
Mar-20
FERMENTA BIOTECH
Mar-21
SANDU PHARMA/
FERMENTA BIOTECH
5-Yr Chart
Click to enlarge
High Rs27442 6.1%   
Low Rs10218 4.8%   
Sales per share (Unadj.) Rs68.3130.8 52.2%  
Earnings per share (Unadj.) Rs1.014.7 6.9%  
Cash flow per share (Unadj.) Rs1.821.8 8.3%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs41.3120.8 34.2%  
Shares outstanding (eoy) m7.0828.85 24.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.32.5 10.9%   
Avg P/E ratio x18.422.4 82.2%  
P/CF ratio (eoy) x10.415.1 68.8%  
Price / Book Value ratio x0.52.7 16.6%  
Dividend payout %017.0 0.0%   
Avg Mkt Cap Rs m1339,520 1.4%   
No. of employees `000NANA-   
Total wages/salary Rs m69582 11.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4843,773 12.8%  
Other income Rs m584 5.4%   
Total revenues Rs m4883,857 12.7%   
Gross profit Rs m15826 1.8%  
Depreciation Rs m6203 2.7%   
Interest Rs m4190 2.3%   
Profit before tax Rs m9516 1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m291 2.2%   
Profit after tax Rs m7425 1.7%  
Gross profit margin %3.021.9 13.7%  
Effective tax rate %21.617.6 122.7%   
Net profit margin %1.511.3 13.2%  
BALANCE SHEET DATA
Current assets Rs m2243,096 7.2%   
Current liabilities Rs m1132,093 5.4%   
Net working cap to sales %22.926.6 86.3%  
Current ratio x2.01.5 133.8%  
Inventory Days Days1883 21.7%  
Debtors Days Days35658 5.4%  
Net fixed assets Rs m1903,371 5.6%   
Share capital Rs m71144 49.1%   
"Free" reserves Rs m2223,342 6.6%   
Net worth Rs m2923,486 8.4%   
Long term debt Rs m01,104 0.0%   
Total assets Rs m4146,468 6.4%  
Interest coverage x3.13.7 83.7%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.6 200.2%   
Return on assets %2.89.5 29.3%  
Return on equity %2.512.2 20.2%  
Return on capital %4.615.4 30.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m02,551 0.0%   
Fx outflow Rs m01,035 0.0%   
Net fx Rs m01,516 0.0%   
CASH FLOW
From Operations Rs m62626 9.9%  
From Investments Rs m-1-416 0.2%  
From Financial Activity Rs m-54-11 468.9%  
Net Cashflow Rs m8205 3.7%  

Share Holding

Indian Promoters % 45.0 62.6 72.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 100.0%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 55.0 37.4 146.9%  
Shareholders   10,508 4,502 233.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   CAPLIN POINT  BHARAT PARENTALS  SEQUENT SCIENTIFIC  GUJ.THEMIS.  BIOFIL CHEMICALS  



Today's Market

Sensex Ends 207 Points Lower as Metal & Banking Stocks Witness Selling; Axis Bank Tanks 7%(Closing)

Indian share markets witnessed volatile trading activity during closing hours today and ended lower.

Related Views on News

Most Popular

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

Up 31,500% in a Year! This Packaging Company Sheds its Penny Stock Status(Views On News)

Oct 18, 2021

What's driving the relentless rally in this packaging company?

Insider Alert! Promoters are Increasing their Stakes in these 5 Companies(Views On News)

Oct 19, 2021

Promoters of many small and mid-cap companies are raising their stakes since the last few quarters.

The One Company Riding the Auto Revolution Beyond EVs(Profit Hunter)

Oct 22, 2021

It's not just about batteries taking over the internal combustion engine. Bigger disruptive forces are coming along with electrification.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANDU PHARMA SHARE PRICE


Oct 27, 2021 (Close)

TRACK SANDU PHARMA

  • Track your investment in SANDU PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANDU PHARMA 5-YR ANALYSIS

COMPARE SANDU PHARMA WITH

MARKET STATS